Toggle Offcanvas
...
 
钙通道阻滞剂招标

钙通道阻滞剂招标

查看钙通道阻滞剂招标,RFP和合同。自2002年以来,竞标具有最佳,最全面的招标平台的钙通道阻滞剂的招标。 对于各种规模的公司来说,竞标钙通道阻滞剂招标非常有利可图。招标当局和私人公司释放了数千份价值数百万的合同,用于采购钙通道阻滞剂。

全球招标是致力于招标和政府合同的最大平台。全球台人拥有超过20年的招标业务经验,提供了最广泛,最可靠的招标/RFP/合同数据库。该平台汇总了公共和私人资源的合同,与超过50万买家的庞大网络建立了联系。我们细致的过程采用了先进的人工智能,涉及从十万来源收集信息。然后,将数据智能分类为数千个子类别,以方便过滤并以用户友好的格式显示,以快速理解。

除了招标信息外,我们还提供深入的钙渠道阻滞剂市场分析,出价咨询服务以及对顶级投标者和获胜者的见解。 立即注册以立即访问无限的钙通道阻滞剂招标,高级搜索过滤器,市场分析,行业趋势,招标培训和24/7客户支持。

4 Live Notices for 钙通道阻滞剂招标

Showing 1 to 4

Subject: Electronic Auction - Regular Acquisition Of Drugs Belonging To Group 09.C.10.A (Lipid Modifying Agents, Isolated), Group 09.C.09.C (Angiotensin Ii Antagonists, Isolated), Group 09.C.03.A (Descenting Loop Diuretics, Thiazides), Group 09.C.09.D (Angiotensin Ii Antagonist, Association), Group 09.C.09.A (Angiotensin Converting Enzyme (Ace) Inhibitors, Isolated), Group 09.C.08.D (Selective Calcium Channel Blockers With Direct Cardiac Effect), Group
country Brazil
posting date18 Jan 2025
deadline01 Feb 2025
* Price Register * Regular Acquisition Of Drugs Belonging To Group 09.C.10.A Lipid Modifying Agents, Isolated, Group 09.C.09.C Angiotensin Ii Antagonists, Isolated, Group 09.C.03.A Descending Loop Diuretics, Thiazides, Group 09.C.09.D Angiotensin Ii Antagonist, Association, Group 09.C.09.A Angiotensin Converting Enzyme Ace Inhibitors, Isolated, Group 09.C.08.D Selective Calcium Channel Blockers With Direct Cardiac Effect, Group
country Brazil
posting date17 Jan 2025
deadline29 Jan 2025
Subject: Electronic Auction - Potential Acquisition Of Standardized Medicines Belonging To Groups: 09.C.07.A - Beta Blocking Agents, 09.C.01.E - Other Cardiac Preparations, 09.C.08.C - Selective Calcium Channel Blockers With Mainly Vascular Effects, 09.C.02.A - Centrally Acting Antiadrenergic Agents And 09.C.01.C - Cardiac Stimulants, Excluding Cardiac Glycosides, In Srp, To Meet The Needs Of Ses Df, According To Specifications And Quantities Contained In Annex I Of E.
country Brazil
posting date14 Jan 2025
deadline28 Jan 2025
* Price Record * Potential Acquisition Of Standardized Drugs Belonging To Groups: 09.C.07.A - Beta Blocking Agents, 09.C.01.E - Other Cardiac Preparations, 09.C.08.C - Selective Calcium Channel Blockers With Mainly Vascular Effects, 09.C.02.A - Centrally Acting Antiadrenergic Agents And 09.C.01.C - Cardiac Stimulants, Excluding Cardiac Glycosides, In Srp, To Meet The Needs Of Ses - Df, According To Specifications And Quantities Contained In Annex I Of E
country Brazil
posting date13 Jan 2025
deadline23 Jan 2025

Share Share this page